Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5771354

O=C(CCc1cnoc1-c1ccc(F)cc1)NCCc1cccnc1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
GAA P10253 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NAMPT P43490 2/20 0.44
LMNA P02545 3/20 0.44
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
CACNA1B Q00975 1/20 0.41
APBA1 Q02410 1/20 0.41
APAF1 O14727 1/20 0.41
PABPC1 P11940 1/20 0.41
CASP6 P55212 1/20 0.41
CASP8 Q14790 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
EPHX2 P34913 1/20 0.41
TBXAS1 P24557 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5773866 0.92 ALDH1A1 (0.48) ALDH1A1GAAMEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL5773317 0.92 CYP3A4 (0.53) ALDH1A1GAAKMT2ALMNACYP1A2
Trifluoroacetic Acid SCHEMBL5773568 0.90 EPHX2 (0.52) GAAMEN1KMT2ANAMPTCYP1A2
SCHEMBL5773900 0.86 CYP1A2 (0.52) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
Trifluoroacetic Acid SCHEMBL5774473 0.84 CYP3A4 (0.52) ALDH1A1MEN1KMT2ANAMPTLMNA
Trifluoroacetic Acid SCHEMBL5774844 0.83 HDAC4 (0.40) ALDH1A1GAAMEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL5771828 0.83 GSK3B (0.42) ALDH1A1GAAKMT2ANAMPTLMNA
Trifluoroacetic Acid SCHEMBL5776953 0.83 PKM (0.48) ALDH1A1NAMPTLMNACYP3A4TBXAS1
Trifluoroacetic Acid SCHEMBL5775717 0.82 GSK3B (0.44) MEN1KMT2ACYP1A2CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL5777437 0.81 ACKR3 (0.41) ALDH1A1LMNAMAPK1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR ALDH1A1 1045/4885GAA 2207/4885MEN1 2811/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 ALDH1A1 682/4885GAA 1930/4885MEN1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.